| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,955 |
5,419 |
$596K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
246 |
236 |
$29K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
263 |
252 |
$22K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
248 |
240 |
$10K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
152 |
152 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
39 |
36 |
$3K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
43 |
42 |
$2K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
52 |
44 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
17 |
15 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
32 |
32 |
$181.06 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
119 |
118 |
$21.41 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
12 |
12 |
$10.99 |
| 81003 |
|
13 |
13 |
$7.08 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
26 |
26 |
$0.00 |